NYSE : EMR
-$5.56 (-3.42%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-08-05 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-08-05 | Citigroup | Buy | Buy | Maintain |
| 2026-08-05 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-07-17 | JP Morgan | Neutral | Overweight | Upgrade |
| 2026-05-07 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-05-06 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-05-06 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-04-01 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-04-01 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-02-09 | Stephens & Co. | Equal Weight | Equal Weight | Maintain |
| 2026-02-05 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-02-05 | Deutsche Bank | Buy | Hold | Downgrade |
| 2026-02-04 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-02-04 | Citigroup | Buy | Buy | Maintain |
| 2026-01-27 | Oppenheimer | Outperform | Perform | Downgrade |
| 2026-01-16 | JP Morgan | Neutral | Neutral | Maintain |
| 2026-01-07 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-01-07 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-01-05 | UBS | Neutral | Buy | Upgrade |